Nothing Special   »   [go: up one dir, main page]

Jones et al., 1996 - Google Patents

Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.

Jones et al., 1996

Document ID
8149246537407741165
Author
Jones H
Zaias N
Publication year
Publication venue
International journal of dermatology

External Links

Snippet

This article focuses on double-mind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail. A larger proportion of patients treated with itraconazole were rated by the investigators as successes in clinical, mycologic, and overall parameters …
Continue reading at search.ebscohost.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetic or similar toilet preparations
    • A61K8/18Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/96Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetic or similar toilet preparations
    • A61K8/18Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Similar Documents

Publication Publication Date Title
Hay et al. Tioconazole nail solution—an open study of its efficacy in onychomycosis
Elewski et al. Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy
Reinel et al. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once‐weekly versus twice‐weekly
JP2001354591A (en) Method for treating onychomycosis
US5639740A (en) Topical moisturizing composition and method
Jones et al. Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
RU2215518C2 (en) Method for increasing quantity of anagenic hair, method for decreasing hair falling out, method for increasing diameter of hair stem, method for increasing hair thickness, method for increasing time for hair growth
JP2012514644A (en) Cyclosporine composition for enhancing nail growth
Delescluse Itraconazole in tinea versicolor: a review
Kuokkanen et al. Fluconazole in the treatment of onychomycosis caused by dermatophytes
Montero-Gei et al. Fluconazole in the treatment of severe onychomycosis.
Batter et al. Skin and Nail Mycoses: Treatment with Ketoconazole, a New Oral Antimycotic Agent: Haut‐und Nagelmykosen: Behandlung mit Ketoconazole, einem neuen oralen Antimykotikum
MXPA06012426A (en) Antifungal drug delivery.
JP2008531640A (en) Antifungal composition comprising sertaconazole and hydrocortisone and / or antibacterial quinolone compound
US6413555B1 (en) Composition and method of treating nail infections
Hay et al. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole
Ginter et al. An intermittent itraconazole 1‐week dosing regimen for the treatment of toenail onychomycosis in dermatological practice: Intermittierende Pulstherapie mit Itraconazol bei Zehennagel‐Onychomykose: Erfahrungen in der dermatologischen Praxis
Baran et al. Chemical avulsion with urea nail lacquer
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
Decroix Tinea pedis (mocassin-type) treated with itraconazole.
Nolting et al. Double‐blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses
Swenor Is permethrin 5% cream effective for rosacea?
Oyeka et al. Isoconazole nitrate versus clotrimazole in foot and nail infections due to Hendersonula toruloidea, Scytalidium hyalinum and dermatophytes: Isoconazolnitrat versus Clotrimazol bei Fu‐und Nagelinfektionen durch Hendersonula toruloidea, Scytalidium hyalinum und Dermatophyten
WO1998042348A1 (en) Topical moisturizing composition and method
Amichai et al. Fluconazole 50 mg/day therapy in the management of chronic paronychia